GD2.CAR T-CELLS AUGMENTED WITH A CONSTITUTIVELY ACTIVE INTERLEUKIN-7 RECEPTOR FOR TREATMENT OF PEDIATRIC CNS TUMORS

被引：0
|
作者：
Omer, B. [1 ]
Lin, F. [1 ]
Stuckert, A. [1 ]
Rooney, C. [2 ]
机构：
[1] Baylor Coll Med, Pediat Hematol Oncol, Houston, TX 77030 USA
[2] Baylor Coll Med, Cell & Gene Therapy, Houston, TX 77030 USA
来源：
HUMAN GENE THERAPY | 2023年 / 34卷 / 21-22期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
O002
引用
收藏
页码：A2 / A2
页数：1
相关论文
共 33 条
  • [21] Are B7-H3 CAR-T cells the future universal treatment for pediatric brain tumors?
    Bourdeaut, Franck
    NEURO-ONCOLOGY, 2021, 23 (06) : 872 - 873
  • [22] CLAUDIN 6 AS A NOVEL IMMUNOTHERAPEUTIC TARGET FOR CHIMERIC ANTIGEN RECEPTOR (CAR)-T CELLS IN THE TREATMENT OF PEDIATRIC SOLID TUMORS
    Madsen, Peter
    Dickson, Conor
    Harvey, Kyra
    Wilson, Cullen
    Patterson, Luke
    Stern, Allison
    Griffin, Crystal
    Storm, Phillip
    Resnick, Adam
    Gaida, Matthias
    Rengstl, Benjamin
    Schlitter, Anna
    Tureci, Ozlem
    Sahin, Ugur
    Flemmig, Carina
    Foster, Jessica
    PEDIATRIC BLOOD & CANCER, 2023, 70 : S146 - S146
  • [23] Interleukin-7 treatment promotes the differentiation pathway of T-cell-receptor-αβ cells selectively to the CD8+ cell lineage
    Varas, A
    Vicente, A
    Jiménez, E
    Alonso, L
    Moreno, J
    Muñoz, JJ
    Zapata, AG
    IMMUNOLOGY, 1997, 92 (04) : 457 - 464
  • [24] GD2-specific chimeric antigen receptor-modified T cells for the treatment of refractory and/or recurrent neuroblastoma in pediatric patients
    Yu, Lihua
    Huang, Lulu
    Lin, Danna
    Lai, Xiaorong
    Wu, Li
    Liao, Xu
    Liu, Jiale
    Zeng, Yinghua
    Liang, Lichan
    Zhang, Guanmei
    Wang, Bin
    Wu, Zhu
    Tao, Shaohua
    Liu, Yuchen
    Jiao, Cheng
    Chang, Lung-Ji
    Yang, Lihua
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (10) : 2643 - 2652
  • [25] GD2-specific chimeric antigen receptor-modified T cells for the treatment of refractory and/or recurrent neuroblastoma in pediatric patients
    Lihua Yu
    Lulu Huang
    Danna Lin
    Xiaorong Lai
    Li Wu
    Xu Liao
    Jiale Liu
    Yinghua Zeng
    Lichan Liang
    Guanmei Zhang
    Bin Wang
    Zhu Wu
    Shaohua Tao
    Yuchen Liu
    Cheng Jiao
    Lung-Ji Chang
    Lihua Yang
    Journal of Cancer Research and Clinical Oncology, 2022, 148 : 2643 - 2652
  • [26] A promising approach of GD2-specific chimeric antigen receptor (CAR) T cells with CD28/4.1BB costimulatory domains for treatment of GD2+sarcomas
    De Angelis, B.
    Camera, A.
    Orlando, D.
    Guercio, M.
    Sinibaldi, M.
    Cembrola, B. M.
    Caruso, S.
    Abbaszadeh, Z.
    Bovetti, K.
    Milano, G. M.
    Russo, I.
    De Vito, R.
    Quintarelli, C.
    Locatelli, F.
    HUMAN GENE THERAPY, 2019, 30 (11) : A69 - A70
  • [27] Optimal interleukin-7 receptor-mediated signaling, cell cycle progression and viability of T-cell acute lymphoblastic leukemia cells rely on casein kinase 2 activity
    Melao, Alice
    Spit, Maureen
    Cardoso, Bruno A.
    Barata, Joao T.
    HAEMATOLOGICA, 2016, 101 (11) : 1368 - 1379
  • [28] DIFFERENTIAL-EFFECTS OF INTERLEUKIN-7 AND INTERLEUKIN-2 ON T-CELL RECEPTOR GAMMA-DELTA-EXPRESSING CELLS WITHIN CD4(-)CD8(-) POSTNATAL HUMAN THYMOCYTES
    HE, W
    KABELITZ, D
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1993, 102 (04) : 321 - 326
  • [29] LOCOREGIONAL ADMINISTRATION OF B7-H3-CAR T CELLS EXPRESSING 41BB LIGAND FOR PEDIATRIC PATIENTS WITH PRIMARY CNS TUMORS: PRELIMINARY RESULTS FROM A PHASE I STUDY
    Bertrand, Kelsey C.
    Kostecka, Anna
    Smith, Kyle
    Han, Katie
    Chiang, Jason
    Pinto, Soniya
    Tlais, Dana
    Selukar, Subodh
    Orr, Brent
    Hanzlik, Emily
    Langfitt, Deanna
    Metais, Jean-Yves
    Lockey, Timothy
    Willis, Catherine
    Fazio, Frank
    Shanmugam, Raghu
    Tian, Liqing
    Walhart, Tara
    Wang, Yu
    Allmon, Patricia
    Perry, Scott
    Schell, Sarah
    Adams, Polly
    Ward, Meghan B.
    Meehl, Michaela
    Akel, Salem
    Poston, Leigh
    Bag, Asim
    Mack, Stephen C.
    Leggas, Markos
    Klimo, Paul
    Gajjar, Amar
    Thomas, Paul
    Robinson, Giles W.
    Park, Julie R.
    Crawford, Jeremy Chase
    Gottschalk, Stephen
    Northcott, Paul A.
    Krenciute, Giedre
    Derenzo, Christopher
    NEURO-ONCOLOGY, 2024, 26
  • [30] THYMUS-DERIVED CYTOKINE(S) INCLUDING INTERLEUKIN-7 INDUCE INCREASE OF T-CELL RECEPTOR-ALPHA BETA+ CD4-CD8- T-CELLS WHICH ARE EXTRATHYMICALLY DIFFERENTIATED IN ATHYMIC NUDE-MICE
    KENAI, H
    MATSUZAKI, G
    NAKAMURA, T
    YOSHIKAI, Y
    NOMOTO, K
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (08) : 1818 - 1825
1234